Oculus Innovative Sciences (OCLS) 3.14 $OCLS
Temper Dow Growth Optimism on Volume Concerns
at The Street - Wed Apr 30, 5:40PM CDT
The Dow closed at a new 2014 high, but with lack of buying volume, traders and investors need to be cautious.
What a Dizzying Day in the Markets
at The Street - Mon Apr 28, 4:13PM CDT
The DJIA and the S&P 500 once again led to the upside. How long can we have the DJIA and S&P vs. the Nasdaq and Russell 2000?
Oculus Innovative Sciences' Partner, More Pharma, Launches Microcyn(R)-Based Oral and Throat Infection Treatment Product in Mexico
GlobeNewswire - Tue Apr 22, 7:08AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries, today announced the commercialization in Mexico of the first product under the Microdacyn60(R) Oral Care brand intended for use as an adjunct treatment in both mouth and throat infections. Commercialized under the brand name Microdacyn60(TM) Bucofaringeo(TM), it is now available in Mexican pharmacies. At the same time, the More Pharma sales team is introducing the treatment to general practitioners along with ear, nose and throat specialists throughout Mexico.
Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation
GlobeNewswire - Wed Apr 09, 8:22AM CDT
-- First International Consensus Guidelines published in December 2013 issue of Journal of Plastic and Reconstructive Surgery
Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO
GlobeNewswire - Wed Apr 02, 8:43AM CDT
-- Board Committees Restructured
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
GlobeNewswire - Thu Mar 27, 7:14AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced the appointment of Sharon Barbari to its board of directors, effective March 26, 2014.
Why Oculus Innovative Sciences (OCLS) Stock Is Up Today
at The Street - Wed Mar 26, 1:42PM CDT
Facebook's (FB) recently-announced acquisition of the privately-held Oculus VR, which makes virtual-reality gaming headsets called Oculus Rift, provided a major boost to Oculus VisionTech (OTVZ) and Oculus Innovative Sciences (OCLS) on Wednesday...
Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:
5 Stocks Ready for Breakouts
at The Street - Fri Mar 21, 12:48PM CDT
These stocks look poised to break out and trade higher from current levels.
Nasdaq stocks posting largest percentage decreases
AP - Fri Mar 21, 12:24PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Uptrend Call Working As Oculus Innovative Sciences Stock Rises 37.4% (OCLS)
Comtex SmarTrend(R) - Thu Mar 20, 9:14AM CDT
SmarTrend identified an Uptrend for Oculus Innovative Sciences (NASDAQ:OCLS) on March 5th, 2014 at $4.01. In approximately 2 weeks, Oculus Innovative Sciences has returned 37.41% as of today's recent price of $5.51.
5 Stocks Poised for Breakouts
at The Street - Fri Mar 14, 12:25PM CDT
These stocks look ready to break out and trade higher from current levels.
4 Under-$10 Stocks to Trade for Breakouts
at The Street - Fri Feb 28, 7:02AM CST
These under-$10 stocks are within range of triggering breakout trades.
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
GlobeNewswire - Thu Feb 27, 8:52AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced the appointment of Russell ("Russ"
Harrison to its board of directors, effective February 26, 2014.
Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering
GlobeNewswire - Fri Feb 21, 9:00PM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today that it has entered into definitive agreements with two life sciences-focused institutional investors for the sale of 450,620 units, consisting of shares of common stock, and Series A and Series B warrants, at a per unit price of $3.00 per share. The total amount sold consisted of a combination of: (1) 450,620 shares of its common stock; (2) Series A warrants to purchase up to 450,620 shares of common stock at an exercise price of $3.00 per share and a term of five years; and (3) Series B warrants to purchase up to 1,400,000 shares of common stock at an exercise price of $3.63 per share. The Series B warrants are not exercisable for six months following the closing of the IPO and have a term of 18 months. The Series B warrants have not vested and will not vest until the completion of the initial public offering (IPO) by the company's subsidiary, Ruthigen, Inc. The Series B warrants terminate on March 31, 2014, if the Ruthigen IPO has not occurred by that date.
Company To Provide Video Surveillance & Security Platform for Marijuana Facilities in Rapidly Evolving Cannabis Industry
PR Newswire - Thu Feb 20, 7:45AM CST
Medical marijuana briefing: companies prepare for increased production as sector quickly expands: DirectView Holdings, Inc. (OTC: DIRV), PetroTech Oil and Gas, Inc. (OTC: PTOG), Dewmar International BMC Inc. (OTC: DEWM), Nuvilex, Inc. (OTC: NVLX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS)
Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico
GlobeNewswire - Wed Feb 19, 7:10AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announced a regulatory approval in Mexico for the company's new Microcyn60(R) Oral Care family of products intended for use as an adjunct treatment in both mouth and throat infections.
Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014
GlobeNewswire - Thu Feb 13, 3:05PM CST
-- Microcyn(R) Scar Management HydroGel Approved by FDA in U.S. and Ministry of Health in Mexico During Quarter
Temper Dow Growth Optimism on Volume Concerns
at The Street - Wed Apr 30, 5:40PM CDT
The Dow closed at a new 2014 high, but with lack of buying volume, traders and investors need to be cautious.
What a Dizzying Day in the Markets
at The Street - Mon Apr 28, 4:13PM CDT
The DJIA and the S&P 500 once again led to the upside. How long can we have the DJIA and S&P vs. the Nasdaq and Russell 2000?
Oculus Innovative Sciences' Partner, More Pharma, Launches Microcyn(R)-Based Oral and Throat Infection Treatment Product in Mexico
GlobeNewswire - Tue Apr 22, 7:08AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries, today announced the commercialization in Mexico of the first product under the Microdacyn60(R) Oral Care brand intended for use as an adjunct treatment in both mouth and throat infections. Commercialized under the brand name Microdacyn60(TM) Bucofaringeo(TM), it is now available in Mexican pharmacies. At the same time, the More Pharma sales team is introducing the treatment to general practitioners along with ear, nose and throat specialists throughout Mexico.
Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation
GlobeNewswire - Wed Apr 09, 8:22AM CDT
-- First International Consensus Guidelines published in December 2013 issue of Journal of Plastic and Reconstructive Surgery
Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO
GlobeNewswire - Wed Apr 02, 8:43AM CDT
-- Board Committees Restructured
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
GlobeNewswire - Thu Mar 27, 7:14AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced the appointment of Sharon Barbari to its board of directors, effective March 26, 2014.
Why Oculus Innovative Sciences (OCLS) Stock Is Up Today
at The Street - Wed Mar 26, 1:42PM CDT
Facebook's (FB) recently-announced acquisition of the privately-held Oculus VR, which makes virtual-reality gaming headsets called Oculus Rift, provided a major boost to Oculus VisionTech (OTVZ) and Oculus Innovative Sciences (OCLS) on Wednesday...
Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:
5 Stocks Ready for Breakouts
at The Street - Fri Mar 21, 12:48PM CDT
These stocks look poised to break out and trade higher from current levels.
Nasdaq stocks posting largest percentage decreases
AP - Fri Mar 21, 12:24PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Uptrend Call Working As Oculus Innovative Sciences Stock Rises 37.4% (OCLS)
Comtex SmarTrend(R) - Thu Mar 20, 9:14AM CDT
SmarTrend identified an Uptrend for Oculus Innovative Sciences (NASDAQ:OCLS) on March 5th, 2014 at $4.01. In approximately 2 weeks, Oculus Innovative Sciences has returned 37.41% as of today's recent price of $5.51.
5 Stocks Poised for Breakouts
at The Street - Fri Mar 14, 12:25PM CDT
These stocks look ready to break out and trade higher from current levels.
4 Under-$10 Stocks to Trade for Breakouts
at The Street - Fri Feb 28, 7:02AM CST
These under-$10 stocks are within range of triggering breakout trades.
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
GlobeNewswire - Thu Feb 27, 8:52AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced the appointment of Russell ("Russ"
Harrison to its board of directors, effective February 26, 2014. Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering
GlobeNewswire - Fri Feb 21, 9:00PM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today that it has entered into definitive agreements with two life sciences-focused institutional investors for the sale of 450,620 units, consisting of shares of common stock, and Series A and Series B warrants, at a per unit price of $3.00 per share. The total amount sold consisted of a combination of: (1) 450,620 shares of its common stock; (2) Series A warrants to purchase up to 450,620 shares of common stock at an exercise price of $3.00 per share and a term of five years; and (3) Series B warrants to purchase up to 1,400,000 shares of common stock at an exercise price of $3.63 per share. The Series B warrants are not exercisable for six months following the closing of the IPO and have a term of 18 months. The Series B warrants have not vested and will not vest until the completion of the initial public offering (IPO) by the company's subsidiary, Ruthigen, Inc. The Series B warrants terminate on March 31, 2014, if the Ruthigen IPO has not occurred by that date.
Company To Provide Video Surveillance & Security Platform for Marijuana Facilities in Rapidly Evolving Cannabis Industry
PR Newswire - Thu Feb 20, 7:45AM CST
Medical marijuana briefing: companies prepare for increased production as sector quickly expands: DirectView Holdings, Inc. (OTC: DIRV), PetroTech Oil and Gas, Inc. (OTC: PTOG), Dewmar International BMC Inc. (OTC: DEWM), Nuvilex, Inc. (OTC: NVLX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS)
Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico
GlobeNewswire - Wed Feb 19, 7:10AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announced a regulatory approval in Mexico for the company's new Microcyn60(R) Oral Care family of products intended for use as an adjunct treatment in both mouth and throat infections.
Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014
GlobeNewswire - Thu Feb 13, 3:05PM CST
-- Microcyn(R) Scar Management HydroGel Approved by FDA in U.S. and Ministry of Health in Mexico During Quarter
